April 27: Archimedis Digital, a life sciences-focused IT services company, announced a significant expansion of its AI-led capabilities with the scaling of its AI Centre of Excellence (CoE) in Tiruchirappalli, alongside an ambitious plan to double its workforce over the next 12 months. This strategic move underscores the company’s focus on building deep AI expertise tailored to the life sciences sector, even as global demand shifts toward intelligent, data-driven systems across pharma, biotech, and medical devices.
The Tiruchirappalli-based AI CoE has been established as a dedicated hub for artificial intelligence, machine learning, and data science innovation, supporting the development of next-generation digital platforms and AI-led solutions for global clients. The centre is already witnessing rapid scale-up, with a strong pipeline of AI-driven projects across pharmacovigilance, regulatory compliance, and digital transformation initiatives in life sciences.
Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital said
“Today, in the life sciences sector, AI is no longer limited to automation. It plays an important role in supporting expert decision-making. At Archimedis Digital, we recognize that accuracy, accountability, and compliance are critical in highly regulated environments. Our Center of Excellence is designed to ensure AI is always guided by human expertise and aligned with evolving regulatory requirements. By combining domain knowledge with scalable AI solutions, we help simplify compliance while delivering practical outcomes and maintaining high standards of clinical and operational integrity.”
Archimedis Digital currently operates with a workforce of approximately 250–300 employees, with a majority based in Chennai and a fast-growing team in Tiruchirappalli. The company plans to double its headcount within the next year, with hiring heavily skewed toward AI and data-centric roles. Notably, around 50% of new hires will bring expertise in AI, machine learning, and data science, while the remaining workforce will strengthen domain capabilities across life sciences and core engineering.
The hiring strategy reflects a clear shift in industry needs, where AI systems increasingly require strong human oversight, domain accountability, and contextual expertise, particularly in highly regulated sectors such as pharmaceuticals. A defining pillar of Archimedis Digital’s expansion is its Tier-2 talent strategy, with Tiruchirappalli emerging as the primary growth engine.
The company is actively tapping into high-potential talent pools beyond traditional metros, focusing on candidates from diverse socio-economic backgrounds and investing in structured training to build specialized capabilities. This approach not only ensures higher talent retention and long-term workforce stability, but also aligns with the company’s model of nurturing domain-led AI talent rather than relying solely on conventional tech hiring ecosystems.
Building on the success of the Chennai headquarters, Archimedis Digital has designated Tiruchirappalli as the primary location for the AI Center of Excellence. This strategic expansion supports a hybrid talent model designed to bridge the gap between deep domain knowledge and AI application. With a strong pipeline of AI-led engagements and expanding global demand, Archimedis Digital is positioning itself to scale both capability and capacity in tandem. The company’s integrated approach, combining AI innovation, domain depth, and a distributed talent strategy, is expected to play a key role in supporting its next phase of growth.
